BioCentury
ARTICLE | Company News

Serono receives Saizen EU approval

August 15, 2001 7:00 AM UTC

Serono (SRA; SWX:SEO) received European marketing approval for its Saizen somatropin recombinant human growth hormone to treat adult growth hormone deficiency. SRA plans to launch the product in sever...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article